| Catalog Number |
07026889190 |
| Medical Device Problem Code |
False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/27/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
We received an allegation about discrepant results for 1 patient sample tested with elecsys anti-hcv ii assay on a cobas e 801 analytical unit.The initial result was 22.3 coi (positive).The patient questioned the initial result.On (b)(6) 2026: the elecsys anti-hcv ii result was 26.0 coi (positive).It is unclear if a new sample was drawn and tested or if the original sample was repeated.A question was asked for clarification, but no answer was provided.Hcv rna (tianlong, gentier 96e) test result: < 50 iu/ml (negative).Abbott ahcv result: 0.07 s/co (tested at another hospital and interpreted as negative).
|
| |
|
Additional Manufacturer Narrative
|
|
The cobas e 801 analytical unit serial number was (b)(6).The calibration and qc were acceptable.The visual check of the sample showed no visible clots.Per the labeled specificity claim of the assay: single false positive results can occur with the elecsys anti-hcv ii assay.The product labeling states: "reactive: all initially reactive or borderline samples should be retested in duplicate using the elecsys anti-hcv ii assay." the product labeling also states: "repeatedly reactive: confirmation via supplemental methods (e.G.Immunoblot or detection of hcv rna).If one or both measurements remain borderline the analysis of a follow-up sample is recommended." the product labeling states: "for diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.The elecsys ahcv ii assay performs within specifications.The cause of the event could not be determined.
|
| |
|
Search Alerts/Recalls
|